CIC
TMO icon

Crawford Investment Counsel’s Thermo Fisher Scientific TMO Stock Holding History

Crawford Investment Counsel’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.91M Sell
5,921
-10
-0.2% -$5.43K 0.05% 176
2025
Q4 		$3.44M Buy
5,931
+3
+0.1% +$1.7K 0.06% 176
2025
Q3 		$2.88M Sell
5,928
-19
-0.3% -$8.84K 0.05% 176
2025
Q2 		$2.41M Sell
5,947
-5
-0.1% -$2.09K 0.04% 175
2025
Q1 		$2.96M Hold
5,952
– – 0.05% 173
2024
Q4 		$3.1M Buy
5,952
+22
+0.4% +$12.1K 0.06% 172
2024
Q3 		$3.67M Buy
5,930
+85
+1% +$50.3K 0.06% 160
2024
Q2 		$3.23M Sell
5,845
-13
-0.2% -$7.45K 0.06% 156
2024
Q1 		$3.4M Sell
5,858
-1,411
-19% -$792K 0.06% 150
2023
Q4 		$3.86M Sell
7,269
-4
-0.1% -$1.94K 0.08% 145
2023
Q3 		$3.68M Sell
7,273
-127
-2% -$67.7K 0.08% 141
2023
Q2 		$3.86M Sell
7,400
-13
-0.2% -$7.01K 0.08% 142
2023
Q1 		$4.27M Buy
7,413
+3
+0% +$1.69K 0.09% 133
2022
Q4 		$4.08M Buy
7,410
+18
+0.2% +$9.54K 0.09% 133
2022
Q3 		$3.75M Sell
7,392
-8
-0.1% -$4.48K 0.09% 138
2022
Q2 		$4.02M Buy
7,400
+216
+3% +$119K 0.09% 133
2022
Q1 		$4.24M Sell
7,184
-7
-0.1% -$4.02K 0.08% 142
2021
Q4 		$4.8M Sell
7,191
-108
-1% -$67.4K 0.09% 142
2021
Q3 		$4.17M Buy
7,299
+212
+3% +$116K 0.09% 146
2021
Q2 		$3.58M Buy
7,087
+57
+0.8% +$26.9K 0.07% 156
2021
Q1 		$3.21M Sell
7,030
-22
-0.3% -$10.5K 0.07% 155
2020
Q4 		$3.29M Buy
7,052
+98
+1% +$46K 0.08% 144
2020
Q3 		$3.07M Buy
6,954
+43
+0.6% +$17.8K 0.08% 133
2020
Q2 		$2.5M Buy
6,911
+21
+0.3% +$7.04K 0.07% 138
2020
Q1 		$1.95M Sell
6,890
-2
-0% -$631 0.07% 146
2019
Q4 		$2.24M Buy
6,892
+64
+0.9% +$19.4K 0.06% 156
2019
Q3 		$1.99M Buy
6,828
+1,210
+22% +$346K 0.06% 156
2019
Q2 		$1.65M Buy
5,618
+1,167
+26% +$321K 0.05% 158
2019
Q1 		$1.22M Hold
4,451
– – 0.04% 171
2018
Q4 		$996K Hold
4,451
– – 0.03% 163
2018
Q3 		$1.09M Hold
4,451
– – 0.03% 166
2018
Q2 		$922K Hold
4,451
– – 0.03% 169
2018
Q1 		$919K Sell
4,451
-851
-16% -$179K 0.03% 169
2017
Q4 		$1.01M Hold
5,302
– – 0.03% 167
2017
Q3 		$1M Buy
5,302
+300
+6% +$54.3K 0.03% 164
2017
Q2 		$873K Hold
5,002
– – 0.03% 165
2017
Q1 		$768K Buy
5,002
+887
+22% +$136K 0.03% 173
2016
Q4 		$581K Sell
4,115
-894
-18% -$132K 0.02% 188
2016
Q3 		$797K Sell
5,009
-43
-0.9% -$6.63K 0.03% 175
2016
Q2 		$746K Buy
5,052
+100
+2% +$14.8K 0.03% 175
2016
Q1 		$701K Buy
4,952
+1,702
+52% +$228K 0.03% 177
2015
Q4 		$461K Sell
3,250
-26
-0.8% -$3.47K 0.02% 193
2015
Q3 		$401K Buy
3,276
+26
+0.8% +$3.39K 0.02% 206
2015
Q2 		$422K Sell
3,250
-537
-14% -$70K 0.02% 198
2015
Q1 		$509K Buy
3,787
+537
+17% +$69.2K 0.02% 185
2014
Q4 		$407K Hold
3,250
– – 0.01% 194
2014
Q3 		$396K Hold
3,250
– – 0.01% 198
2014
Q2 		$384K Hold
3,250
– – 0.01% 196
2014
Q1 		$391K Buy
3,250
+750
+30% +$89.2K 0.01% 191
2013
Q4 		$278K Buy
+2,500
New +$249K 0.01% 214

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Crawford Investment Counsel's TMO Position: Q1 2026 in Review

Crawford Investment Counsel reduced its Thermo Fisher Scientific (TMO) stake by 0.17% in Q1 2026, selling an estimated $5.43K and leaving 5,921 shares worth $2.91M. The position accounts for 0.05% of the portfolio, ranked #176.

Crawford Investment Counsel first reported a position in TMO in Q4 2013 and has held it in 50 quarters since. The position peaked at $4.8M in Q4 2021. 2,590 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Crawford Investment Counsel held 5,921 shares of Thermo Fisher Scientific worth $2.91M as of Q1 2026.
  • Crawford Investment Counsel sold 10 Thermo Fisher Scientific shares in Q1 2026, an estimated $5.43K.
  • Thermo Fisher Scientific made up 0.05% of Crawford Investment Counsel's portfolio in Q1 2026, its #176 holding.
  • Crawford Investment Counsel first reported a position in Thermo Fisher Scientific in Q4 2013 and has held it in 50 quarters since.
  • Crawford Investment Counsel's Thermo Fisher Scientific position peaked at $4.8M in Q4 2021.
  • 2,590 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Crawford Investment Counsel's 13F filing for Q1 2026, filed 15 May 2026.